REPX vs TMO · P/E 12, rev $410.2M vs P/E 24, rev $44.56B
Riley Exploration Permian Inc (REPX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Riley Exploration Permian Inc (REPX) is a oil & gas e&p company listed on AMEX.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported REPX revenue for 2024-12-31 was $410.2M. Net income was $88.9M. Revenue was up 9.4% from 2023-12-31 to 2024-12-31. REPX currently screens at market cap $727.0M and trailing P/E 11.7.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
REPX currently screens at market cap $727.0M and trailing P/E 11.7. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the REPX and TMO stock pages for the full models.
Not investment advice.